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Numerous studies have established the involvement of both the airways and the lung 
parenchyma in pulmonary constrictor responses. 
In the present thesis, the effects of three iv.-delivered pulmonary constrictor agents of 
pathophysiological importance (histamine, methacholine and endothelin-1) on the mechanical 
properties of the airways and lung tissues were studied in dogs, rats and guinea pigs. 
A noninvasive assessment of the respiratory mechanics, using the low-frequency forced 
oscillation technique, was applied to separate the airway and tissue components. The model-
based evaluation of the pulmonary input impedance data was used to characterize the airway 
and tissue mechanics under control conditions and during pulmonary constriction. To 
circumvent the problems of flow measurements in a small animal, we adopted the wave-tube 
technique to measure the mechanical impedance of the respiratory system in rats and guinea 
pigs. In agreement with previous findings in other mammals, the fitting of the impedance data 
to a model involving an airway and a constant-phase tissue compartment resulted in no 
systematic errors. 
Our studies on the partitioning of the lung response into airway and parenchymal 
components have confirmed that the constrictor agents act on both the airway and tissue 
compartments. Although the differences in species (in terms of the distribution of receptors 
and the quantity of airway smooth muscle) and/or methodological factors may influence the 
pattern and the magnitude of the lung response, the constrictor agent and its delivery route 
seem to be the primary determinants of the shares of the airway and tissue compartments in 
the provoked constriction. 
These studies demonstrated that different underlying mechanisms and/or sites of action 
were activated in response to the effects of the three pulmonary constrictor agents. Analysis of 
the model performance further indicated that, at high doses of all the agonists studied, the 
constriction of the peripheral airways was highly heterogeneous. 
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INTRODUCTION 
Pulmonary constrictor agents - Pathophysiological overview 
Histamine (HIST) and endothelin-1 (ET-1) are important inflammatory and 
proinflammatory mediators of pathophysiological effects in endotoxemia, sepsis, adult 
respiratory distress syndrome (ARDS) and asthma. 
The release of HIST, mainly from mast cells, may play a role in the pathogenesis of 
sepsis both in humans and in experimental animals [Brackett et al. 1990], In animal models of 
sepsis and in ARDS patients, the plasma ET-1 concentration is significantly increased [Sanai 
et al. 1996, Mitaka et al. 1998], The main mechanism responsible for the rise in ET-1 level is 
the upregulation of ET-1 synthesis, which occurs in part in the lungs. 
ARDS is an endpoint syndrome of acute lung injury of diverse etiology, being a result 
of complex pathophysiological processes located mainly in the lung. The lung injury in 
ARDS is the result of an inflammatory process, which develops under the influence of vaso-
and bronchoactive mediators produced by damaged or activated endothelial and epithelial 
cells, platelets and leukocytes that have been sequestered in the pulmonary microcirculation. 
ARDS is characterized by pulmonary hypertension, hypoxemia, increased microvascular 
permeability with interstitial and alveolar edema, increased airway resistance, decreased 
pulmonary compliance and a reduced functional residual capacity. The development of ARDS 
in most cases is associated with Gram-negative septicemia and septic shock. Thus, septically 
induced ARDS has frequently been studied in animal models, involving the infusion of live 
Gram-negative bacteria or bacterial lipopolysaccharide, i.e. endotoxin, into experimental 
animals. In these models, an acute pulmonary dysfunction occurred, which is the main feature 
of ARDS. Additionally, changes in the lung mechanics (decreased dynamic compliance and 
increased lung resistance resulting from active airway constriction) and pulmonary 
hypertension were consequences of the released mediators (i.e. HIST and ET-1, among 
others) [Forsgren and Modig 1986], 
Bronchial asthma is a chronic inflammatory disease of the airways, characterized by 
airway narrowing and hyperresponsiveness to a variety of bronchoconstrictor stimuli. Airway 
inflammation can be defined as the presence of activated inflammatory cells (mast cells and 
eosinophils). These cells have the capacity to release potent bronchoconstricting mediators 
(e.g. HIST), which are responsible, at least in part, for airway narrowing, mucosal edema, 
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mucus secretion and structural changes, such as epithelial damage, and an altered smooth 
muscle function, including changes in the responsiveness or volume [Barnes 1998], The HIST 
level in bronchoalveolar lavage has been shown to correlate with the parameters of disease 
activity in asthma [Casale et al. 1987], The inadequate pulmonary removal of HIST may be an 
important factor in the mediation of pathophysiological responses, such as bronchial smooth 
muscle contraction, increased capillary permeability, mucus production and an increased 
airway permeability [Said 1982], 
The airway epithelium has a protective function against noxious stimuli. The epithelial 
cells are able to release a variety of bronchoactive mediators, which modulate the function of 
the underlying smooth muscle cells. As ET-1 induces airway smooth muscle contraction and 
has a role in airway hyperresponsiveness, and as an upregulation of ET-1 expression occurs in 
the epithelial cells, ET-1 may have a potential pathophysiological role in bronchial asthma 
[Springall et al. 1991, Hay et al. 1993a, Barnes 1998]. 
Acute inflammation in the airways elicits changes in the airway mechanics, leading to 
bronchial hyperresponsiveness, which means an increased sensitivity and maximal response 
to bronchoconstrictor stimuli. In clinical practice and research, bronchoprovocation tests 
based on methacholine (MCh) or HIST inhalation is frequently used to assess the airway 
hyperresponsiveness. 
Lung mechanics - Methodological overview 
During breathing, the activity of the respiratory muscles results in changes in flow, 
pressure and volume in the lungs. Lung mechanics deals with the forces and resistances that 
determine the flow of air into and out of the lungs. The primary function of the lung is to meet 
the demand for O2 in the tissues. The bronchial tree, extending from the trachea to the 
terminal respiratory units, conducts the air to the alveolar surface, where gas transfer occurs 
between the inspired air and the gas dissolved in the blood of the pulmonary capillaries. There 
are differences in structure and function between small (<2 mm in diameter) and large 
airways. The total cross-sectional area of small airways is greater than that of large airways. 
The flow is the same for all cross-sections, but the linear velocity of the gas (flow/cross-
sectional area) is smaller in the small airways. Hence, small airways are characterized by 
laminar flow, whereas the flow in large airways is turbulent in consequence of the greater 
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linear velocities of the gas. In the lung periphery, the large cross-sectional areas result in 
lower overall resistance in the small airways. The airway resistance depends on the number, 
length, and cross-sectional area of the airways. Among these, the most variable component of 
the airway resistance is the cross-sectional area, which is determined, for a given anatomical 
structure, by the balance between two opposing forces: those tending to distend the walls (the 
retraction of the lungs by the negative pleural pressure) and those tending to contract the walls 
(airway smooth muscle and elastic elements). Neurohumoral mediators and the local changes 
in gas tension also influence the airway resistance and trigger compensation mechanisms to 
match ventilation/perfusion. 
The airway smooth muscle is a major determinant of the airway caliber. The effect of 
muscle contraction depends on the location and the density of the muscle fibers. In the large 
airways, muscle contraction results in a high level of rigidity, as the muscle fibers oppose the 
tips of the cartilage, whereas in the medium and small bronchi both the caliber and the length 
of the bronchus are reduced during contraction. During contraction, the airway lumen 
decreases, to an extent depending on the shortening of the muscle fibers and the thickness of 
the airway wall. The extent of the shortening is determined by the tensile force generated in 
the muscle and by the magnitude of opposing forces (elastic elements in the airway wall and 
the surrounding parenchyma). 
In the early days of respiratory research, the mechanical properties of the lung were 
characterized by resistive losses due to the changes in airway diameter, and the elasticity 
attributed to the lung parenchyma. Conventionally, to estimate the resistance and elastance of 
the respiratory system under physiological conditions requires the measurement of flow, 
volume and transrespiratory pressure. However, it was demonstrated that the parenchymal 
tissue is a viscoelastic material associated with energy losses [Bayliss and Robertson 1939], 
and it exhibits hysteretic behavior both in vivo [Ludwig et al. 1987, 1992] and in vitro 
[Fredberg et al. 1993], due to different structural materials (collagen-elastin-proteoglycan 
matrix and surfactant under control conditions, and contractile elements during constriction). 
The tissue constriction can be caused by constriction of the smooth muscle elements in the 
lung parenchyma, the tissue matrix and the alveolar ducts, which results in changes in the 
alveolar geometry and affects the rheological properties of the surfactant. 
Thus, the total lung resistance (RL) is the sum of the airway resistance (Raw), which is 
the resistance to flow in the airways, and the tissue resistance (Rti), which reflects the 
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dissipative energy losses of the lung parenchyma. Rti has been found to account for the major 
proportion of RL under control conditions [Ludwig et al. 1987, Brusasco et al. 1989, Nagase 
et al. 1992, Ingenito et al. 1993, Nagase et al. 1997], The tissue component has been reported 
to be responsible for 25-82% of RL in dogs [Brusasco et al. 1989], 60% in rabbits [Nagase et 
al. 1992], 27-33% in guinea pigs [Ingenito et al. 1993] and 33% in rats [Nagase et al. 1997], 
During constriction, bronchoactive agents exert significant effects on both Raw and Rti. 
The responses of Rti may even exceed those of Raw [Kariya et al. 1989, Hantos et al. 1992b, 
Romero et al. 1992, Ingenito et al. 1993, Pellegrino et al. 1993, Robatto et al. 1993, Nagase et 
al. 1994], 
The development of the alveolar capsule technique [Fredberg et al. 1984, Brusasco et al. 
1989, Hantos et al. 1992b] made it possible to partition RL into airway and tissue components 
and to investigate the role of the lung parenchyma in RL. The results achieved with this 
frequently used technique have confirmed the importance of the tissue resistance in both 
normal and constricted lungs. However, it is an invasive technique, which limits its 
applicability, and the alveolar pressure (PA) can be measured only on small local areas of the 
lung. Since PA exhibits a significant heterogeneity during constriction, the PA values on which 
the partitioning of RL into Raw and Rti is based may be highly accidental [Hantos et al. 
1992b, Peták et al. 1993, Nagase et al. 1994], 
Another means of separation of the airway and tissue components is the noninvasive 
assessment of respiratory mechanics by the forced oscillation technique. This was originally 
developed for human medicine [DuBois et al. 1956], but it has also been applied extensively 
to animals. Briefly, the respiratory mechanical impedance can be measured, with analysis of 
the responses (pressure and flow) of the respiratory system to externally generated, multiple-
frequency signals. The respiratory impedance contains complex information on the resistive, 
elastic and inertial properties of the respiratory system [Peslin and Fredberg 1986], although 
at the usual oscillation frequencies (above 2-5 Hz) the drawing of inferences on the airway 
and tissue components is not straightforward. 
The measurement of low-frequency pulmonary input impedance [Hantos et al. 1986] 
and the derived model parameters adequately characterize the mechanical properties of the 
airways and lung tissues in control states [Hantos et al. 1987, 1992a,b, Peták et al. 1993, 
Lutchen et al. 1994, 1996,] and during pulmonary constriction [Hantos et al. 1992b, Lutchen 
et al. 1994, 1996], 
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Histamine 
In lung pharmacology, the early findings concerning the mechanical effects of HIST on 
isolated airway preparations demonstrated size- and species-dependent effects on the airways. 
Both bronchiolar and larger airway preparations from dog lungs responded with a marked 
contraction to HIST, with the same sensitivity [Persson and Ekman 1 9 7 6 ] , 
It has been shown that bronchoactive agents (HIST, MCh, acetylcholine and serotonin) 
cause dose-related changes in the mechanical properties of the airways and parenchyma in 
whole lungs. The lung mechanical responses to these drugs are generally manifested as 
increases in RL and simultaneous decreases in dynamic compliance [Colebatch et al. 1966, 
Hirshman et al. 1 9 8 0 , Mitzner et al. 1992 ] , 
HIST has been demonstrated to affect the mechanical properties of the airways and lung 
tissues by increasing Raw and Rti [Colebatch et al. 1966, Fredberg et al. 1985, Ludwig et al. 
1 9 8 7 , 1989 , 1 9 9 1 , Lauzon et al. 1 9 9 2 , Bates et al. 1 9 9 3 , 1 9 9 4 , Lutchen et al. 1 9 9 4 ] , However, 
various data have been reported on the relative contributions of Raw and Rti to the increase in 
RL. Lauzon et al. [ 1 9 9 2 ] and Bates and Peslin [ 1 9 9 3 ] found that smooth muscle contraction in 
the peripheral bronchi and blood vessels results in changes in the lung tissue mechanics and 
that the constriction in the central airways leads to the changes in Raw. 
Additionally, Mitzner et al. [ 1 9 9 2 ] suggested that, after administration of a 
bronchoconstrictor agent, the airway constriction passively distorts the lung parenchyma via 
the airway-parenchyma mechanical interdependence. They concluded that the 
intraparenchymal contractile cells were not involved in the changes in parenchymal 
mechanics. 
In the present study, therefore, we examined the relationship between the airway and 
tissue responses to iv. HIST, and addressed the hypothesis that bronchoconstriction accounts 
for the greater part of the lung tissue response. 
Methacholine 
MCh is a synthetically available, chemical analog of acetylcholine, a 
parasympathomimetic agonist stimulating muscarinic receptors. 
A number of studies have demonstrated that the mechanical effects of MCh depend on 
the route of delivery. In a canine model, RL increased, while the static lung compliance 
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decreased during the iv. infusion of MCh [Breen et al. 1987], Sato et al. [1993] found that the 
elevations in RL and tissue elastance were accompanied by inhomogeneous ventilation of the 
lungs after MCh administration. In guinea pigs, significantly higher airway responses were 
accompanied by a significantly elevated Rti [Ingénito et al. 1993], However, in rats, greater 
tissue responses than airway constrictor responses were observed after iv. MCh administration 
[Nagase et al. 1994], Moreover, Salerno et al. [1995] demonstrated that the iv. infusion of 
MCh activated the peripheral contractile elements, leading to increases in Rti, dynamic 
elastance and hysteresivity (ri). Lutchen et al. [1996] reported equal increases in Raw and 
tissue damping (G) (44-46%) during MCh infusion; however, the increase in tissue elastance 
(H) was much smaller. 
Experiments with aerosolized MCh resulted in different data from those with iv. MCh 
[Kariya et al. 1989, Romero et al. 1992, Pellegrino et al. 1993, Robatto et al. 1993, Nagase et 
al. 1994], Inhalation of MCh increased Raw and Rti to similar degrees in dogs [Robatto et al. 
1993], Romero et al. [1992] reported substantial changes in the intrinsic viscoelastic 
properties of the lung parenchyma in rabbits, without a change in Raw. In healthy and 
asthmatic human subjects, aerosolized MCh did not elicit tissue responses, but changes in the 
airways were observed [Kariya et al. 1989, Pellegrino et al. 1993], 
The above-mentioned animal studies involved the use of an alveolar capsule technique 
to measure PA, and the sampling of PA may lead to false estimations of airway and tissue 
responses to a constrictor agent [Hantos et al. 1992b], especially in the case of an enhanced 
peripheral inhomogeneity due to MCh [Nagase et al. 1994], 
Our goal was to study the effects of the iv. administration of MCh on the mechanical 
properties of the airway and tissue, with special regard to the relative contributions of the 
airways and parenchyma to the MCh-induced constriction. In the experiments, the low-
frequency impedance (ZL) was measured, and the airway and tissue responses were separated 
by fitting a model containing airway and parenchymal compartments to the ZL data. 
Endothelin 
Cardiovascular system 
The endothelins (ETs) are a family of three peptides (ET-1, ET-2 and ET-3), each 
consisting of 21 amino acids. All three isoforms have impressive biological effects. ET-1 was 
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originally isolated from a conditioned medium of cultured porcine aortic endothelial cells 
[Yanagisawa et al. 1988], ET-1 is produced from preproendothelin-1, and proendothelin-1 or 
big endothelin-1 [Rubanyi and Polokoff 1994], The circulating levels of ET-1 are very low, 
but its concentration at the endothelium/vascular smooth muscle interface is much higher than 
in the blood. ET-1 is released mostly abluminally, where it binds to the specific receptors on 
the vascular smooth muscle cells. ET-1 may, therefore, act locally, and should be regarded as 
a locally-acting paracrine hormone rather than as a circulating endocrine hormone. Though 
the circulating levels of ET-1 do not reflect the local production of this peptide, plasma ET-1 
measurements may be useful and of diagnostic value in different disease states [Haynes and 
Webb 1993, Rubanyi and Polokoff 1994], The synthesis and secretion of ET-1 is induced by 
different stimuli, such as epinephrine, thrombin, cytokines, hypoxia, ischemia and shear 
stress. Moreover, the production of ET-1 is regulated by inhibitory stimuli; endothelium-
derived nitric oxide and prostacyclin may contribute to the overall hemodynamic effects of 
ET-1 [Vane and Botting 1991], Under normal physiological conditions, the balance between 
the production of ET-1 and nitric oxide contributes to the maintenance of the basal vascular 
tone [Rubanyi and Polokoff 1994], After iv. injection, ET-1 quickly disappears from the 
circulation because of the elimination by the lungs during the first passage [De Nucci et al. 
1988], 
Two types of ET receptors (ETA and ETB) have been cloned on the cells of mammalian 
species, and a putative ETc receptor type has also been suggested [Sakurai et al. 1990, 
Lippton et al. 1993], ETA receptors are present on the smooth muscle cells of blood vessels, 
while ETB receptors exist mainly on endothelial cells; however, they are also present on the 
smooth muscle cells of certain vascular beds. ETA receptors preferentially bind ET-1, whereas 
ETB receptors display an equal affinity for all isoforms of ET. The vasoconstrictor effects of 
ET-1 are mediated predominantly through the ETA receptors, while activation of the ETB 
receptors cause both vasoconstriction (ETB2) and vasodilation (ETBI) in certain blood vessels 
[Clozel et al. 1992, Rubanyi and Polokoff 1994], The vasodilator action is probably linked to 
the increased production of nitric oxide and prostacyclin [De Nucci et al. 1988], 
Lung 
Besides the profound action in the cardiovascular system, the ETs play important roles 
in the regulation of the pulmonary function under physiological and pathological conditions. 
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Several studies on the synthesis of ET-1 in the tracheal and bronchial epithelial cells, type II 
pneumocytes and alveolar macrophages [Durham et al. 1993, Markewitz et al. 1995, 
Kobayashi et al. 1997] have revealed the importance of this peptide in the lung. ET-1 
produces paracrine effects, as it is synthetized in the airway epithelium and elicits constriction 
in the adjacent smooth muscle cells. The peptide also causes smooth muscle cell proliferation, 
increased mucus secretion and activation of alveolar macrophages [Michael and Markewitz 
1996], 
Autoradiographic studies have identified specific binding sites for ET-1 in the airways 
of various animal species and of the human [Henry et al. 1990, Goldie et al. 1996]. In some 
species (human, guinea pig and rat), but not in mouse, there was a positive correlation 
between the airway responsiveness to ET-1 and the density of ET-1 binding sites [Henry et al. 
1990], Studies on the cellular locations demonstrated ET-1 binding sites in the alveolar 
capillary endothelial cells, bronchial smooth muscle cells, epithelial cells, alveolar type II 
fibroblasts and pneumocytes [Goldie et al. 1996], The two receptor types coexist in the lung; 
however, there are interspecies differences in the proportions of the ETA and ETB receptors 
[Henry et al. 1990, Hay et al. 1993b, Goldie et al. 1996], In the guinea pig lung, the ETB 
receptors predominate (ETB 80%; ETA 12%) [Goldie et al. 1996], Differences in the 
proportions of the two receptor types throughout the respiratory tract within a species have 
also been demonstrated: a higher density of ETB receptors was found in the bronchi than in 
the trachea [Hay et al. 1993b], 
Lung mechanical changes 
On a molar basis, ET-1 is a less potent constrictor in the airways than in the vascular 
tissues. In vitro and in vivo studies have indicated ET-1-induced bronchoconstriction 
.[Macquin-Mavier et al. 1989, Schumacher et al. 1990, Pons et al. 1991, White et al. 1991, 
Lueddeckens et al. 1993, Noguchi et al. 1993, Battistini et al. 1994, Nagase et al. 1995, 
Polakowski et al. 1996 , ] , which is mediated by both receptor types in the guinea pig lung 
[Battistini et al. 1994 , Nagase et al. 1 9 9 5 ] , However, these studies inferred 
bronchoconstriction from the changes in the global lung mechanical parameters. For example, 
ET-1 elicited dose-dependent increases in the peak pulmonary inflation pressure (PIP) [Pons 
et al. 1 9 9 1 , Lueddeckens et al. 1 9 9 3 , Noguchi et al. 1 9 9 3 ] , or in RL, with a concurrent 
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decrease in the dynamic lung compliance following iv. injection into guinea pigs [Macquin-
Mavier et al. 1989, Schumacher et al. 1990, White et al. 1991, Polakowski et al. 1996], The 
measurements of these global lung mechanical parameters relate to the changes in the 
mechanical properties of both the airways and the parenchyma. The only study in which the 
airway and parenchymal responses to ET-1 were separated was reported by Nagase et al. 
[1995], who measured the local PA through one or two capsules in guinea pigs. However, as 
noted above, separation based on measurements of PA involves uncertainties because of the 
heterogeneity of PA [Petak et al. 1993], 
The aims of our studies were to investigate the dose-response characteristics of the 
airways and tissues to ET-1, and to establish how ET-1 alters the separate mechanical 
properties of the airways and the parenchyma in guinea pigs. 
Selective and non-selective ET receptor antagonists are available which can facilitate a better 
understanding of the effects of the different ET receptor types in the biological responses and 
the mechanism of ET-1 action. BQ-610, a specific antagonist of the ETA receptors [Ishikawa 
et al. 1992], is the linear derivative of the cyclic pentapeptide BQ-123. It is more potent than 
BQ-123 and more selective for ETA than for ETB receptors. ETR-Pl/fl, another type of ETA 
receptor antagonist [Baranyi et al. 1995], is a synthetic 15 amino acid, "antisense-homology 
box"-derived peptide with anti-ETA receptor activity both in vitro and in vivo. IRL 1038 is a 
selective antagonist of the ETB receptor [Urade et al. 1992]; it has much higher affinity for 
ETB receptors than for ETA receptors and inhibits the endothelium-dependent relaxation 
induced by ET-1 in the isolated rat aorta. 
The aim of this study was to assess whether pretreatment with ET receptor antagonists 
(BQ-610, ETR-Pl/fl and IRL 1038) influences the particular pulmonary responses to the 
administration of exogenous ET-1. Two ET-1 doses were chosen from those used in our 
previous study [Adamicza et al. 1999]: a smaller dose caused slight and homogeneous 
changes, and a higher dose elicited significant changes in the airway inertance, suggesting an 
inhomogeneous peripheral airway constriction. 
In both studies involving an ET-1 challenge, a model-based evaluation of ZL was used to 
determine the mechanical responses in the airways and lung tissues. 
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AIMS OF THE THESIS 
The overall purpose of the research rescribed in this thesis was to investigate the lung 
mechanical responses to three bronchoactive agents (HIST, MCh and ET-1) that are of 
particular pathophysiological significance in respiratory research. 
We examined the airway and lung tissue mechanical properties by using the low-
frequency forced oscillation technique to measure ZL. The airway and lung tissue responses 
were separated by fitting the ZL data to a model containing the two compartments. This 
separation is based on the fact that the frequency-dependent characteristics of the airway and 
tissue components are different. 
The concrete aims of the work reported here are as follows: 
To examine the relationship between airway and tissue responses to iv. HIST, and to 
test the hypothesis that the bronchoconstriction accounts for the greater part of the lung tissue 
response in dogs. 
To study the effects of the iv. administration of MCh on the mechanical properties of 
the airways and the parenchyma, and in particular the relative contributions of these 
compartments to the MCh-induced constriction in rats. 
To investigate the dose-response characteristics of the airways and tissues following iv. 
ET-1 administration, and the mechanism whereby ET-1 alters the separate mechanical 
properties of the airways and the parenchyma in guinea pigs. 
To reveal the role of the ET receptors in the mechanical responses of the pulmonary 
airways and tissues to iv. ET-1 in guinea pigs. 
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MATERIALS AND METHODS 
Animal preparations 
The studies were approved by the University Ethical Committee for the Protection of 
Animals in Scientific Research, and were performed in adherence to the NIH guidelines on 
the use of experimental animals. 
Histamine challenge 
Six mongrel dogs of either sex weighing 23.2 ± 2.6 kg were studied. The animals were 
anesthetized with pentobarbital sodium (30 mg/kg iv.), and a catheter was introduced into a 
femoral artery for monitoring of the systemic arterial blood pressure (BP). Tracheotomy was 
performed, and a metal tube (15-mm inner diameter) was inserted into the trachea. 
Mechanical ventilation was maintained with a Harvard respirator at frequencies of 12-15 
breaths/min and a tidal volume of 20 ml/kg, with 5-C111H2O positive end-expiratory pressure. 
Bilateral incisions were then made between the fifth and sixth ribs, and the sternum was split 
and widely retracted. The dogs were paralyzed with a dose of 0.1 mg/kg of pipecuronium 
bromide. Supplemental doses of pentobarbital sodium (10 mg/kg) and pipecuronium bromide 
(0.025 mg/kg) were given hourly to maintain a stable level of anesthesia and paralysis, 
respectively. 
Methacholine challenge 
Experiments were performed on five adult male Sprague-Dawley rats (330-450 g). The 
animals were anesthetized with pentobarbital sodium (30 mg/kg ip.) and placed in a supine 
position on a heating pad. A carotid artery and a jugular vein were cannulated for monitoring 
of the BP and for drug delivery, respectively. Tracheostomy was performed, and a 30-mm 
plastic cannula (2-ram inner diameter) was inserted into the trachea. Mechanical ventilation 
was maintained with a Harvard small-animal respirator, with a tidal volume of 3 ml and a 
frequency of 90/min. The end-expiratory pressure was set at 2.5 CIT1H2C), the thorax was 
opened with a midline sternotomy, and the ribs were widely retracted. Paralysis was 
accomplished with pipecuronium bromide (0.2 mg/kg initial dose, supplemented every 20 
min by 0.05 mg/kg). Additional anesthetic (10 mg/kg pentobarbital sodium) was given every 
40 min. 
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Endothelin challenge without and with endothelin receptor antagonists 
The experiments were carried out on guinea pigs (weighing 380-600 g) anesthetized 
with pentobarbital sodium (30 mg/kg ip.). The animals were placed on a heating pad to 
maintain the body temperature at 37 °C. The right carotid artery and left jugular vein were 
cannulated for the measurement of BP and drug administration, respectively. A plastic 
cannula (length=30 mm, internal diameter=2 mm) was inserted into the trachea and connected 
to a small-animal respirator (Harvard App. Inc., South Natick, MA, USA) delivering a tidal 
volume of 6 ml/kg at a frequency of 70/min. Following a midline sternotomy, the chest was 
widely opened and a positive end-expiratory pressure of 2.5 cmHaO was applied. The guinea 
pigs were paralyzed with pipecuronium bromide (0.2 mg/kg). Additional doses of 
pentobarbital sodium (10 mg/kg) and pipecuronium bromide (0.05 mg/kg) were given as 
needed to maintain anesthesia and paralysis, respectively. 
At the end of the experiments, the animals were killed with an overdose of pentobarbital 
sodium, and lung tissue samples were taken. The ratio of the wet weight to the dry weight of 
the lungs (WW/DW) was calculated to estimate the amount of pulmonary edema. The 
WW/DW values obtained in the main study population were compared with those calculated 
from another group of untreated normal guinea pigs (n=7). Moreover, lung tissue samples 
were fixed in 10% neutral-buffered formalin and paraffin embedded. Sections of each 
sampled tissue were stained with hematoxylin-eosin and periodic acid-Schiff. The alveoli 
were inspected for edema fluid, polymorphonuclear cells and macrophages, and the alveolar 
capillaries for congestion. 
Impedance measurements and model fitting 
Histamine challenge 
Small-amplitude pseudorandom volume oscillations (in the frequency range 0.2-21.1 
Hz) from a computer-controlled closed-box loudspeaker system were introduced into the 
trachea. The volume delivered was - 4 0 ml peak-to-peak at the airway opening; this 
corresponded to tracheal airflow values <220 ml/s peak-to-peak. Airway opening pressure 
was measured with a Validyne MP-45 transducer (Northridge, CA) via a side-tap of the 
tracheal tube, with reference to atmospheric pressure. The tracheal airflow was measured with 
a heated screen pneumotachograph and a Validyne MP-45 transducer. The controlling 
computer was also used for the processing of the measured signals. ZL was computed from 
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the cross-spectra of the flow and pressure signals with the excitation signal, as described 
previously (Hantos et al. 1992b). 
Challenges with methacholine or endothelin without and with endothelin receptor 
antagonists 
The wave-tube method was applied to measure the mechanical impedance of the 
respiratory system [Van de Woestijne et al. 1981], with the modification for small animals 
[Hantos et al. 1987, Peták et al. 1997], A loudspeaker-in-box system and the tracheal cannula 
were connected through a polyethylene wave tube (length=105 cm, inner diameter=2 mm) 
during apneic periods. The mechanical ventilation was interrupted at end-expiration and a 
forcing signal was introduced into the trachea. Before each measurement, the pressure in the 
box chamber was adjusted to 2.5 cnfl^O to keep the transpulmonary pressure unchanged 
during measurements. Lateral pressures were measured with ICS transducers (IC Sensors, 
Milpitas, CA) at the loudspeaker end (Pi) and the trachea cannula end (P2). The computer-
generated small-amplitude pseudorandom signal contained multiple frequency components 
between 0.5 and 21 Hz. The pressure signals were low-pass filtered and digitized by an 
analog-to-digital board of a computer. Fast Fourier transformation was used to calculate the 
pressure transfer function (P1/P2) spectra from the 6-s recordings by using 4-s time windows 
and 97% overlapping. ZL was calculated as the load impedance of the wave tube by using the 
transmission line theory [Frankén et al. 1981, Van de Woestijne et al. 1981]: 
ZL = Z0 sinh (yL)/[(Pi/P2) - cosh (yL)] 
where Zo and y are determined by the geometrical data and the material constants of the tube 
and the air. 
Model fitting 
A model containing an airway and a constant-phase tissue compartment was fitted to the 
ZL data [Hantos et al. 1992a,b]; the term "constant phase" means that, in the tissue 
compartment, the real and imaginary parts decrease with the same power (a) of angular 
frequency (<a): 
ZL = Raw + jcolaw + (G - jH) / CÖ" 
where j is the imaginary unit; the airways were characterized by the frequency-independent 
airway resistance (Raw) and inertance (law); G and H are coefficients of tissue damping 
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(viscance) and elastance, respectively. Parenchymal hysteresivity (r|) was calculated as the 
ratio of dissipated energy to the stored potential energy per unit deformation, q=G/H 
[Fredberg and Stamenovic 1989], Impedance data points corrupted by the heart rate and its 
harmonics were omitted from the model fit. 
Before the experiments, the resistance and inertance of the tracheal cannula were also 
measured, and were subtracted from the corresponding Raw and law. 
Experimental protocols and groups 
Histamine challenge 
Each oscillatory measurement was started after the animal was disconnected from the 
respirator at end-expiration, and lasted for 20 s. HIST (Sigma Chemical) was dissolved in 
normal saline and infused iv. in seven steps, beginning with a rate of 0.25 pg/kg/min (HI), 
with subsequent doubling up to 16 pg/kg/min (H2-H7). The measurements of ZL were made 
in the control state, during infusions of HIST, and 60 min after the last infusion. Both in the 
control state and postinfusion, four measurements were made and the results from the 
repeated measurements were then ensemble-averaged. The time elapsed between every two 
consecutive measurements was 2 min. The measurements during the HIST infusion were 
made in an interval when the BP had reached a steady state. After each oscillatory 
measurement, the lung was hyperinflated by occluding the expiratory outlet of the respirator 
for one respiratory cycle to avoid atelectasis. Before the oscillations, the respirator was 
detached at end-expiration from the tracheal tube, which was connected to the loudspeaker 
chamber preinflated to 5 cnftLO. 
Methacholine challenge 
MCh (methacholine chloride, Sigma Chemical) was dissolved in saline and infused at a 
rate of 1, 2, 4, 8 or 16 pg/kg/min. Before each infusion, the lungs were hyperinflated by 
occluding the expiratory outlet of the respirator for one cycle, i.e. producing two 
superimposed inspirations. Four successive measurements of ZL, were made 1 min apart and 
the infusion was then started. The duration of each infusion was 10 min, and ZL was measured 
30 s after the onset of the infusion and every 1 min thereafter. The infusion was suspended for 
at least 15 min to allow the BP to recover before the next series of control and infusion 
measurements was begun. 
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Endothelin challenge 
The measurements of ZL were made before and following every iv. bolus of ET-1, by 
doubling the doses from 0.125 pg/kg to 2 pg/kg. Prior to each dose, 3 to 6 measurements were 
made to establish the baselines. Before the control measurements, the lungs were 
hyperinflated by superimposing two inspirations to open the possible atelectatic areas. ZL was 
recorded 0.5, 1, 2, 4, 6 and 8 min after each ET-1 bolus. The ZL curves obtained in each of the 
control conditions were ensemble-averaged. The ZL data measured after each dose of ET-1 
were fitted individually, and the parameter values obtained from the 0.5-min recording were 
selected to characterize the constrictor responses. 
Endothelin challenge with endothelin receptor antagonists 
Four measurements of ZL were made under the control conditions (before antagonist 
pretreatment and/or the administration of ET-11 (0.05 nmol/kg) and ET-I2 (0.2 nmol/kg). 
Further ZL measurements were made at 0.5, 1, 2, 4 and 6 min after the administration of each 
of the successive ET-1 boluses. Prior to the control ZL measurements, the lungs were 
hyperinflated by occluding the expiratory line of the respirator for two consecutive cycles to 
prevent atelectasis. This maneuver was repeated at 7 min after each ET-1 dose. The control 
ZL spectra and those recorded after the administration of the ET receptor antagonist were 
averaged separately and then fitted, whereas the ZL data obtained following the administration 
of the two successive doses of ET-1 were fitted individually. The constrictor responses to 
each of the ET-1 doses were characterized by the parameter values obtained from ZL recorded 
at 0.5 min after administration. 
After the surgical procedure, the animals were allowed to stabilize for 20 min. They 
were then randomized into one or other of the five following groups and given ET-1 iv. in two 
successive doses, the first E T - 1 dose (ET-LI) at zero time and the second dose ( E T - 1 2 ) 10 min 
thereafter (group ET-1, n=9), or 20 nmol/kg ETA receptor antagonist BQ 610 (group BQ-
61020, n = 8 ) , or 8 0 nmol/kg E T A receptor antagonist B Q - 6 1 0 (group BQ-610so, n = 6 ) , or 2 0 
nmol/kg ETb receptor antagonist IRL 1038 (group IRL 1038, n=9), or 20 nmol/kg ETA 
receptor antagonist ETR-Pl/fl (Kurabo Ltd., Osaka, Japan) (group ETR-Pl/fl, n=5). The 
antagonist was administered 3 min prior to the first E T - 1 dose (ET-LI) . E T - 1 , B Q - 6 1 0 and 
IRL 1038 were products of Alexis Corporation (Laufelfingen, Switzerland). 
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Statistical analysis 
Data are expressed as means ± SE. The statistical significance of changes in the lung 
mechanical parameters during HIST challenge was evaluated by using Wilcoxon's signed-
rank test. The one-way analysis of variances with Dunnett's multiple comparison procedure 
was used to compare the parameters from the control with those obtained after MCh 
challenges. Friedman repeated measures analysis of variance on ranks with the Student-
Newman-Keuls multiple comparison procedure, and Kruskal-Wallis one-way analysis of 
variance on ranks with the Dunn multiple comparison procedure were used for within-group 
and between-group comparisons, respectively, in the studies with ET challenges. A P value of 
<0.05 was considered statistically significant. 
RESULTS 
Histamine challenge 
The dose-dependent changes in the pulmonary mechanical parameters tended to vary 
from dog to dog. The Raw values did not exhibit statistically significant differences from the 
control value except during the highest rate of infusion (Fig. 1). law changed by less than + 
5% during the infusions and the only significant value was reached postinfiision. 
Significant dose-related increases occurred in G and H at H3 and H4, respectively (Fig. 
2). The mean values of G and H reached their maximum at H7; however, the changes in G (to 
236% of the control value) were much higher than those in H (to 136% of the control value). 
TI was significantly higher than the control value at H3, and increased to 169% of the control 
value at H7. All of the tissue parameters remained slightly but statistically significantly 
elevated after the last HIST infusion. 
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Figure 1. Airway parameters (Raw and law) in the control state (Cont), during the infusion of HIST 
(H1-H7) and 60 min after infusion (PH). Dotted lines denote control (Cont) values. 
* Significantly different from the control value. 
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Figure 2. Lung tissue parameters (G, H and rj) in the control state (Cont), during the infusion of HIST 
(H1-H7) and 60 min after infusion (PH). Dotted lines denote control (Cont) values. * Significantly 
different from the control value. 
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In Fig. 3, the G values normalized by the control data are plotted against the normalized 
H values for each dog. The higher increases in G than those in H are indicated by the upward 
deviations from the line of identity (rpconstant). The postinfusion G and H values did not 
return to the control values (they positioned at the medium-rate infusions). 
Figure 3. Relationship between tissue damping (G) and elastance (H) in the control state, during HIST 
infusion and 60 min after infusion (squares) in 6 dogs (#l-#6). Both parameters were normalized by 
control values (Gc and Hc). Dashed lines denote lines of identity corresponding to constant 
hysteresivity. 
In Fig. 4, Raw is plotted against G for each dog, with both parameters normalized by 
their control values. The data demonstrate that elevations in G may occur before any change 
in Raw. 
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G / G c 
Figure 4. Relationship between airway resistance (Raw) and tissue damping (G), normalized by 
control values (Rawc and Gc), in the control state and during HIST infusion, in 6 dogs (#l-#6). 
Methacholine challenge 
Figure 5 demonstrates the airway parameters obtained in the control state and at the 
different MCh-infusion rates. Raw increased in a dose-related manner, while law remained 
unchanged, except during the highest infusion rate. 
The G values increased significantly during the two higher infusion rates, whereas H 
remained at the control level (Fig. 6). 
MCh induced similar elevations in Raw, G, and q, which reached 270 ± 90%, 340 ± 
150% and 301 ± 102%, respectively, of their control values (Fig. 7). No residual effect of 
MCh was found, and every parameter returned to its baseline value between infusions (data 
not presented). 
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Figure 5. Airway parameters (Raw and law) in the control state (C) and during MCh infusion. 
* Significantly different from the control value. 
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Figure 6. Lung tissue parameters (G, H and rj) in the control state (C) and during MCh infusion. 
* Significantly different from the control value. 
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( n g / k g / m in ) 
Figure 7. Percentage changes (normalized to the control values) in airway resistance (Raw), tissue 
damping (G), tissue elastance (H) and hysteresivity (rf) during MCh infusion. 
Endothelin challenge 
Administration of increasing doses of ET-1 elicited statistically significant increases in 
BP (Fig. 8). 
0 . 1 2 5 0 . 2 5 0 . 5 
E T - 1 (ng /kg ) 
Figure 8. Effects of ET-1 on systemic blood pressure. % change = maximal value during ET-1 x 
100/control value - 100. * P < 0.05. 
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Experimentally observed temporal changes in the airway and tissue parameters during 
successive administrations of ET-1 doses are presented in Fig. 9. The increasing doses of the 
constrictor agent induced monotonous elevations in Raw, G, H and r\ at low doses of ET-1, 
whereas no further increases in Raw and H were observed when the concentration of the ET-1 
dose was increased from 1 to 2 pg/kg. All of the model parameters returned to the baseline 
following the low doses of ET-1; slight irreversible changes were seen only during severe 
constrictions. For all model parameters, peak responses occurred 30 s after the administration 
of ET-1 when the constriction was moderate (following the three or four lowest doses), while 
the parameter maxima were dissociated following the high doses of ET-1. Typically, G and q 
exhibited an instant peak increase after the injection of the bolus, whereas the peak response 
in H was slightly delayed. Raw occasionally followed the changing pattern of G (e.g. after 1 
pg/kg in this example), or displayed a delayed increase (e.g. after 2 pg/kg). Despite this 
asynchrony, the parameter values observed 30 s after the ET-1 administrations adequately 
characterize the lung responses to most of the doses, although this sampling may lead to a 
slight underestimation of the increases in Raw and H during severe constriction. 
0 . 1 2 5 0 . 2 5 0 . 5 1 2 ( n g / k g ) 
Figure 9. Airway (Raw and law) and parenchymal (G,H and q) parameters in control conditions (Cl-
C5) and their peak responses to ET-1. Dotted line denotes baseline (CI) value. * Significant 
difference from the preceding control value. 
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Relative changes in the mechanical parameters in response to increasing doses of ET-1 
are demonstrated in Fig. 10. The percentage increases for each parameter were calculated by 
normalizing the responses to the corresponding baseline values preceding each ET-1 dose. 
The marked increases in Raw and G occurred reasonably in parallel, while the elevations in H 
and q were smaller. The increases in tissue parameters were statistically significant following 
each ET-1 challenge, whereas Raw remained at the baseline after the lowest dose of ET-1, 
and only the last two doses of ET-1 induced marked and statistically significant decreases in 
law. 
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Figure 10. The effects of ET-1 on the values of the mechanical parameters. The responses in the 
parameters were normalized to the control values preceding each ET-1 dose. For definitions, see 
legend to Fig. 9. * P<0.05. 
The ratio WW/DW in the untreated group (4.7±0.13) was significantly lower than that 
obtained from the ET-1-challenged guinea pigs (5.2±0.14; P<0.05). 
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Endothelin challenge with endothelin receptor antagonists 
In this study, the resting BP values were not significantly different between the groups. 
In group ET-1, ET-1 induced significant dose-dependent increases in BP (Fig. 11). The 
maximum values were reached within 1-2 min and BP then declined toward the baseline 
within 10 min. There were no significant differences in ET-1-induced BP changes between 
groups BO-6IO20, IRL 1038 and ET-1, although ET-12 caused a somewhat smaller response in 
group IRL 1038. In groups BO-6108o and ETR-Pl/fl, the increases in BP were significantly 
less than that in group ET-1. 
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Figure 11. Peak responses in blood pressure induced by two ET-1 doses with and without 
pretreatment with ET receptor antagonists. The responses were normalized to the control values 
measured before ET-1 administration. * Significant difference from group ET-1. # Significant 
difference from ET-L in groups ET-1, BO-6102o and IRL 1038. 
Figure 12 presents the characteristic profiles of the changes in the airway and 
parenchymal parameters after each of the two successive doses of ET-1, with and without 
pretreatment with the higher dose of BQ-610 or IRL 1038. There were only slight differences 
in baseline values between the individual groups; however, the control G value for group BO-
61020 was significantly different from that for group ETR-Pl/fl. Both the first and the second 
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doses of ET-1 induced significant increases in Raw, G, H and r| in group ET-1, and this dose-
dependent pattern remained in all groups which received antagonists. The parameters reached 
their maxima within 30 s after the administration of either dose of ET-1, and the peak values 
then gradually declined toward the baseline. In group BO-6IO20, the elevations in the 
respiratory parameters were close to those observed in group ET-1. However, in groups BO-
6108o, IllL 1038 and ETR-Pl/fl, each of the doses of ET-1 evoked significantly smaller 
increases in Raw, G, H and r\. The patterns of change in law were inconsequential: in all 
groups but group B O - 6 I O 2 0 , no statistically significant changes in law were observed after 
either ET-1 dose. 
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Figure 12. Mean airway (Raw and law) and tissue (G, H and rf) parameter profiles induced by two 
successive doses of ET-1 (ET-1, and ET-12) with and without pretreatment with one or other of two 
ET receptor antagonists. ANT: BQ-61080 or IRL 1038. 
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In group ET-1, the durations of significant changes in Raw and H were dose-dependent. 
Significant changes in persisted for 1 min, and those in G for 10 min after each of the ET-1 
doses (Table 1). The lower dose of BQ-610 significantly shortened the duration of changes in 
G, and increased those in r\ after ET-li. The responses in Raw, G and r\ were statistically 
significant only for short intervals in the cases of the higher dose of BQ-610, IRL 1038 and 
ETR-Pl/fl. 
Table 1. Mean durations (min) of significant changes induced in airway (Raw) and parenchymal 
parameters (G, H and n) by two successive ET-1 doses (ET-li and ET-12), with and without 















ET-1 1 6 10 10 6 10 1 1 
BQ-6IO20 6 4 1 6 6 10 4 1 
BQ-610m 0 0 0.5 1 1 6 0 0 
ETR-Pl/fl 0 2 0.5 1 10 6 0 0 
IRL 1038 0 1 0.5 1 10 10 0 0 
Because of the high variations in the baseline data, the percentage changes in the airway 
(Raw) and parenchymal parameters (G, H and "n) were calculated by normalizing the values 
measured at 30 s after each of the ET-1 doses to those obtained before ET-1 administration 
(Fig. 13). ET-1 induced dose-dependent increases in each of these parameters in group ET-1. 
In group BQ-6IO20, the changes in most of the parameters did not differ significantly from the 
corresponding values in group ET-1; only the increase in H was significantly smaller after 
ET-li. The responses in Raw, G, H and r\ after each ET-1 dose were significantly smaller in 
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Figure 13. Changes induced in the parameters Raw, G, H and r] by two successive ET-1 doses (ET-li 
and ET-12) with and without pretreatment with an ET receptor antagonist. The parameters were 
measured at 30 s after each ET-1 dose and are normalized to the control values measured before ET-1 
administration. * Significant difference from the value for group ET-1. 
No significant differences were observed between the groups in the counts of 
polymorphonuclear cells and macrophages; moreover, no signs of alveolar edema were 
observed (data not shown). The absence of edema was supported by the results of gravimetric 
analysis of the tissue samples. For all the antagonist-treated groups, the ratio WW/DW did not 
differ significantly from that for group ET-1 (ET-1: 5.11±0.1, BQ-6102O'. 4.88±0.07, BQ-
61080'. 5.63±0.2, IRL 1038: 5.06±0.1 and ETR-Pl/fl: 5.19±0.1). 
DISCUSSION 
Histamine challenge 
Our data suggest that an iv. HIST challenge can cause constriction in the lung periphery 
without any change in the overall Raw. This type of response to HIST demonstrates that the 
airway and tissue contractions could be dissociated. As the rates of HIST infusion elicit a 
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wide range of responses (from none or relatively small to large) in our study, we consider that 
this type of HIST challenge is appropriate for demonstration of the responsiveness of the 
airways and lung tissues. 
HIST was earlier known only to induce mechanical changes in the lung due to the 
smooth muscle contraction of the airways, i.e. it reduced the airway diameter and increased 
the resistance. Subsequently, a number of authors described an increase in Rti [Colebatch et 
al. 1966, Ludwig et al. 1987, 1989] and changes in lung mechanical impedance [Fredberg et 
al. 1985, Ludwig et al. 1989] after a HIST challenge administered either iv. or as an aerosol. 
Several studies confirmed that HIST increases both Raw and Rti, although there were 
conflicting data on the relative contributions of the two components to the increase in RL 
[Fredberg et al. 1985, Ludwig et al. 1987, 1989, 1991, Lauzon et al. 1992, Bates et al. 1993, 
1994, Lutchen et al. 1994], Ludwig et al. [1987, 1989, 1991] found that the relative increases 
in Raw and tissue viscance were equal, the dose-response behavior of the two components of 
RL was similar, and the peripheral airways responded heterogeneously to HIST. However, in 
all of these studies, HIST was delivered by aerosol. 
Mitzner et al. [1992] suggested that changes in lung tissue mechanics could occur ' 
without any contractile mechanisms in the parenchyma, for there is a mechanical 
interdependence between airway contraction and lung compliance during MCh infusion into 
the bronchial circulation in sheep. The contracted conducting airways lend stiffness to the 
surrounding parenchyma, and, according to the authors, this relationship may be a possible 
reason for the increased RL and a simultaneous decrease in dynamic compliance elicited by 
different bronchoactive agents. Lauzon et al. [1992] and Bates and Peslin [1993] suggested 
that the iv. HIST-induced smooth muscle contraction in the peripheral airways and pulmonary 
blood vessels was responsible for the changes in the tissue mechanical properties, whereas the 
changes in Raw were consequences of the constriction in the central airways. 
Our findings are at variance with the hypothesis of Mitzner et al. [1992]: both G and H i 
increased significantly, whereas there was no discernible change in Raw during the infusion 
of several doses of HIST: the only significant increase in Raw occurred during the highest 
infusion rate. 
Intravenous HIST-induced bronchoconstriction is involved in ventilation inhomogeneity 
and this nonuniform constriction of the conducting airways causes significant, though virtual, 
changes in tissue parameters [Hantos et al. 1992b, Bates et al. 1994], This may be possible 
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during severe constriction, such as during the highest infusion rate in the present study, and 
that by Lutchen et al. [1994], Ludwig et al. [1991] demonstrated that a significant 
heterogeneity was evoked in the peripheral airways after HIST inhalation. 
We observed significant increases in both tissue parameters during HIST infusion. 
Moreover, higher increases were found in G than in H. This process may be the result of 
peripheral inhomogeneity, as mentioned above, or of the intrinsic properties of the tissue, as 
demonstrated by Fredberg et al. [1993] in guinea pig parenchymal strips. The lung tissue has 
separate contractile elements with the ability to respond to bronchoactive agents, so that the 
primary response is a change in elastance; however, changes in the degree of coupling (ri) 
between dissipative and elastic processes also occurred [Ludwig et al. 1989, 1991, 1992, 
Fredberg et al. 1993], In our study, both H and r\ increased, as found previously during a 
HIST challenge [Loring et al. 1981, Lauzon et al. 1992, Bates et al. 1994, Lutchen et al. 
1994], although, interestingly, no change in H occurred along the rpconstant line (Fig. 3), 
demonstrating instantaneous, and possibly primary alterations in the intrinsic t\. 
The effect of HIST on the bronchial smooth muscle tone is complex; it involves both a 
direct contraction by stimulating the Hi-receptors in the airway smooth muscle [Dixon et al. 
1979a, b], and an indirect one by stimulating afferent vagal fibers through rapidly adapting 
receptors in the airways [Vidruk et al. 1977], H2-receptor activity could not be demonstrated 
in the canine airways [Bradley and Russell 1983], 
Our results reveal that constrictor agents may cause significant mechanical changes 
mainly in the lung tissue after HIST challenge, preceding any change in Raw. As concerns the 
interpretation of the findings, it must be taken into account that catecholamines released by 
the systemic administration of HIST can modify the mechanical changes [Staszewska-
Barczak 1965, Colebatch and Engel 1974], 
Methacholine challenge 
This study documents a significant effect of iv. MCh on the airway caliber. As regards 
the airway parameters, the iv. delivery of MCh induced a threefold increase in Raw and no 
change in law. As for the tissue parameters, an elevation in G similar to that in Raw occurred, 
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while no increases in H were found. The differences in behavior of the tissue parameters 
resulted in a significant increase in T]. 
Intravenous MCh significantly changed the airway caliber in a dose-dependent manner. 
It is known that an overwhelming contribution to law is made by the inertance of the central 
airways. As law remained at the baseline level or decreased slightly (except during the highest 
dose), we suggest that iv. MCh induced bronchoconstriction in the peripheral airways. 
r. 
We observed a significant (fourfold) increase in G and no change in H during an iv. 
MCh infusion. These changes are only in partial agreement with those of Lutchen et al. 
[1996], who found, besides the significant increase in G, a statistically significant elevation in 
H. They suggested that during severe constriction the enhanced airway inhomogeneity can 
lead to an artifactual increase in G. Accordingly, there may be two possibilities for the 
changes in G. First, the MCh-induced increase in G can be a consequence of a changed 
intrinsic tissue damping, and second, it can be a result of the peripheral ventilation 
inhomogeneity. We suggest the latter phenomenon, i.e. we attribute the increase in G is 
attributed to inhomogeneous airway constriction during iv. MCh infusion. However, the 4 
possibility that the altered r\ also contributes to the elevation in G (G = ri-H) cannot be ruled 
out. 
In a previous study that also involved Sprague-Dawley rats, significant airway 
responses were associated with elevated tissue responses; both Rti and dynamic elastance 
significantly increased [Nagase et al. 1994], Others, using Brown Norway rats or guinea pigs, 
found large tissue responses [Ingenito et al. 1993, Salerno et al. 1995], The reason for the 
difference between the reported changes in dynamic elastance and our H responses may be 
that dynamic elastance values are calculated at respiratory frequencies, whereas H is a 
frequency-independent elastance coefficient. As suggested by Lutchen et al. [1996], the i 
peripheral airway inhomogeneities increase not only G, but also the positive frequency 
dependence of the effective elastance, whereas the intrinsic elastic and resistive properties of 
the tissues do not change. 
MCh produces smooth muscle contractions by stimulating the muscarinic receptors in 
the airways [Barnes 1990], Since the presence and distribution of the muscarinic receptor 
subtypes is species-dependent, the differences in the MCh responsiveness of the airways and 
the parenchyma are explained by this mechanism. The M3 receptors are located 
predominantly on the airway smooth muscle, and this receptor subtype may be responsible for 
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the airway constriction elicited by iv. MCh. Ml receptors have been detected in the human 
and rabbit peripheral lung, mainly on the alveolar walls, which have been reported to be 
involved in the parenchymal response, and can be reached more easily by aerosolized MCh. 
These interspecies differences must also be considered when the results on one species are 
compared with those on another. 
There are quantitative differences in airway smooth muscle between the various species, 
and this may be an important cause of the variability in the responsiveness to bronchoactive 
agents [Martin et al. 1992], Rats have the lowest sensitivity and the smallest maximal 
responses to MCh, while the larger quantity of airway smooth muscle in guinea pigs is 
associated with a larger maximal response to MCh. 
Besides the differences in muscarinic receptor density and the quantity of airway 
smooth muscle, the effects of aging should also be considered. Nagase et al. [1994] found that 
increasing age decreased dynamic elastance after MCh inhalation in rats. 
In summary, our results demonstrated that MCh induces changes in both the airways 
and the lung tissue, possibly via the stimulation of different receptors, with the airway 
constriction predominating. 
Endothelin challenge 
The airway responses to ET-1 were associated with significant changes in the 
mechanical properties of the lung parenchyma. Increasing concentrations of ET-1 induced 
progressive increases in Raw and monotonous increases in G, while H showed a plateau 
response at the three highest doses. In contrast, law remained at the baseline level when the 
constrictions were mild, but exhibited significant decreases during severe constrictor 
responses. Although the changes in all mechanical parameters were fully reversible after the 
two lowest ET-1 doses, the higher doses caused irreversible parenchymal constrictions, which 
were associated with statistically significant residual increases in Raw. There were no changes 
in the baseline levels of law or q. 
The dose-dependent increases in Raw were associated with no increases in law at low 
ET-1 doses. Since law is thought to be a characteristic parameter of the central airways, this 
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changing pattern suggests a dominance of the periphery in the development of an ET-1-
induced airway constriction. 
At high ET-1 doses, Raw increased further, while significant decreases occurred in law, 
even negative values being attained in most of the animals during severe constriction. This 
controversial changing pattern in the airway parameters can be explained as follows. In our 
study, Raw and law characterize the mechanical properties of the overall bronchial tree. 
While both parameters are proportional to the overall length of the airways, law and Raw are 
inversely related to the first and to the second power, respectively, of the overall bronchial 
cross-sectional area. Therefore, assuming no change in the overall airway length, we would 
expect both Raw and law to increase with a generalized airway constriction. Although, in 
theory, Raw can increase while law decreases if the airway constriction is associated with 
significant airway shortening, the unrealistic negative law parameters obtained at high doses 
of ET-1 cannot be explained on that basis. Therefore, the opposite changes in Raw and law 
during constriction can most probably be attributed to the failure of the model during a severe 
spatial inhomogeneity of the pulmonary constriction. By using a distributed periphery lung 
model to simulate ZL data in control and constricted conditions, Hantos et al. [1992b] 
demonstrated that, in the presence of an inhomogeneous peripheral constriction, the model-
predicted law systematically underestimates the real law. Therefore, the opposite changes in 
Raw and law at high ET-1 doses very probably indicate an inhomogeneous peripheral airway 
constriction. 
We observed significant increases in both parenchymal parameters during iv. 
administration of ET-1. Since the increases in G exceeded those in H, significant elevations 
were obtained in t\. In parenchymal strips obtained from guinea pig lungs, different 
constrictor agents induced greater increases in Rti than in the elastance [Fredberg et al. 1993], 
Those literature data suggested that parenchymal constrictions were always associated with 
significant increases in the intrinsic r\. Accordingly, ET-1 changed the coupling between the 
resistive and elastic properties at the level of the parenchyma, i.e. ET-1 may induce significant 
elevations in the intrinsic t\. 
Inhomogeneous peripheral airway constriction has been shown to increase the 
frequency dependence of RL [Hantos et al. 1992b, Lutchen et al. 1996, Peták et al. 1997] and 
create a significant artifactual component in G due to interregional peripheral ventilation 
[Lutchen et al. 1996], In our study, as H increased significantly in response to ET-1, we 
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suggest that real intrinsic parenchymal constrictions occurred. The finding that, at the highest 
ET-1 dose, there was a significant elevation in G without any further increase in H suggests 
the role of enhanced peripheral inhomogeneity. Although the excessive increase in G may 
also be explained on the basis of a purely tissue reaction, i.e. an elevated r|, the fact that this 
change is accompanied by a fall in law supports the inhomogeneity as the underlying 
mechanism. 
Following low ET-1 doses, each parameter returned to the baseline level; however, after 
severe constrictions, Raw, G and H remained above the baseline. A possible explanation for 
our findings may be that the lung remained constricted after the ET-1-induced responses. 
However, in this case, the parameter t\ would also be expected to remain above the baseline 
level [Fredberg et al. 1993], A further possibility is that the residual changes can be attributed 
to lung volume loss. In our experiments, we performed hyperinflations to eliminate atelectatic 
regions, and therefore the lung volume loss is probably a result of pulmonary edema 
[Grossman et al. 1980], as supported by our finding that the ratios WW/DW were 
significantly higher after ET-1. Increases have likewise been observed in the vascular 
permeability after high doses of ET-1 [Filep et al. 1995], 
The bronchoconstrictor effects of iv. ET-1 were concluded from the increase in RL and 
the decrease in dynamic lung compliance [Macquin-Mavier et al. 1989, Schumacher et al. 
1990, White et al. 1991, Polakowski et al. 1996] or the increase in PIP [Pons et al. 1991, 
Lueddeckens et al. 1993, Noguchi et al. 1993], However, the methods used in these previous 
studies do not allow a detailed investigation of the effects of ET-1 on the airway and lung 
tissue mechanics. It is known that PIP reflects the overall pressure losses in the lungs, 
including those of elastic origin, and RL has a flow resistive airway (Raw) and a viscoelastic 
parenchymal (Rti) component. Only Nagase et al. [1995] separated the ET-l-induced lung 
responses into airway and parenchymal components in guinea pigs and in mice [Nagase et al. 
1996] by measuring the local PA. It has been pointed out that the sampling of one or two 
alveolar regions in a highly inhomogeneously constricted lung makes the capsule-based 
partitioning highly incidental [Hantos et al. 1992b, 1995, Peták et al. 1993, Lutchen et al. 
1996, Peták et al. 1997], In our study, the mechanical properties of the airways and the 
parenchyma were separated on the basis of a global lung mechanical model. 
It is generally accepted that the lung parenchyma contributes to the constrictor response 
of the lungs. In vitro studies on parenchymal strips indicated that alterations occurred at the 
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parenchymal level, although the increases in the tissue mechanics were much smaller than 
those obtained for the whole lung [Fredberg et al. 1993], Alternatively, according to Mitzner 
et al. [1992], airway constriction may lead to parenchymal responses via the mechanical 
interdependence between the airways and the lung tissues. In the present study, we found 
different time courses in the responses of the mechanical parameters. Following a high dose 
of iv.-administered ET-1, the peak responses were manifested first in G and r\, while the 
maximal increases in Raw and H were somewhat delayed. Since several studies document 
that the airway and parenchymal constrictions are dissociated [Bates et al. 1994, Lutchen et al. 
1994, Hantos et al. 1995, Suki et al. 1997], we may conclude that ET-1 induces lung tissue 
constriction by acting on the contractile elements in the parenchyma rather than as a result of 
airway contractions. 
In summary, we have demonstrated that increasing doses of ET-1 affect the mechanical | 
properties of the airways and the parenchyma in guinea pigs in a dose-related manner. The ' 
dose-response curves for the airway and parenchymal mechanical parameters suggest the 
dominance of the peripheral airways in the development of the ET-1-induced constriction. 
Besides a significant inhomogeneous constriction of the peripheral airways, real intrinsic 
increases occurred in the mechanical properties of the parenchyma. Our results further 
indicate that ET-1 has a marked constrictor effect not only on the vascular and bronchial 
smooth muscles but also on the lung parenchyma. 
Endothelin challenge with endothelin receptor antagonists 
This study confirms that the administration of an ETA or ETB receptor antagonist alone 
does not change the basal values of the lung mechanical parameters, which suggests that 
endogenous ET-1 does not play a significant role in the regulation of the resting 
bronchomotor tone in guinea pigs. However, each of the iv. doses of ET-1 significantly 
increased Raw, G, H and r\. Pretreatment with the lower dose of BQ-610 significantly 
decreased the changes only in H after ET-li, whereas the higher dose of the antagonist also 
reduced those in Raw, G and r\. Pretreatment with IRL 1038 or ETR-Pl/fl reduced the 
responses to ET-1 in both the airways and the parenchyma. Thus, it is concluded that ET-1 
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induces mechanical responses via the activation of both ETA and ETB receptors in the airways 
and the parenchyma in the guinea pig lungs. 
In the present study, we used two ETA receptor antagonists (BQ-610 and ETR-Pl/fl) and a 
selective ETB receptor antagonist (IRL 1038) to investigate the roles of the ET receptors in the 
mechanical properties of the airways and the parenchyma. BQ-610 is a highly selective ETA 
receptor antagonist, being an approximately 30 000 times more effective inhibitor of ETA than 
of ETB receptors in vitro [Ishikawa et al. 1992], and it effectively antagonizes the in vivo 
effects of ET-1 on the ETA receptors [Boros et al. 1998, Szalay et al. 1998], ETR-Pl/fl is an 
"antisense-homology box"-derived peptide, which exhibits anti-ETA receptor activity in the 
cardiovascular system both in vitro [Baranyi et al. 1995] and in vivo [Boros et al. 1998, Szalay 
et al. 1998], In addition, it improves the symptoms and hemodynamic parameters in endotoxin 
shock [Baranyi et al. 1998] and in hypodynamic septic rats [Szalay et al. 1998], and inhibits 
the endothelial cell-leukocyte interactions in response to ET-1 in the intestinal 
microcirculation in rats [Boros et al. 1998], IRL 1038 binds specifically to the ETB receptors 
in various mammalian tissues, including the guinea pig lungs [Urade et al. 1992]. 
In the literature, there are no data that are comparable with our recent [Adamicza et al. 
1999] and present findings. Only Nagase et al. [1995] reported parenchymal changes after iv. 
administered ET-1 in guinea pigs in vivo. 
In the present study, similarly as in our previous investigation [Adamicza et al. 1999], the 
two successive doses of ET-1 each caused significant dose-related changes in the mechanical 
properties of the airways and the parenchyma. Raw was increased significantly, without any 
significant change in law. Since law is dominated by the inertance in the central airways, we 
conclude that ET-1 induces airway constriction in the periphery of the lung. 
Autoradiographic studies have demonstrated that ETA and ETB receptors coexist in the 
guinea pig lung, with an ETA:ETB receptor ratio of 1:4 [Goldie et al. 1996], Furthermore, Hay 
et al. [1993b] described regional differences in the distributions of the two ET receptor types 
in the airways. The primary bronchi contain more ETB receptors, whereas the ETA receptors 
predominate in the trachea. The relative contribution of the ETB receptors to 
bronchoconstriction therefore increases in the distal direction along the respiratory tract [Hay 
et al. 1993b]. Pharmacological investigations on isolated guinea pig bronchi provided 
evidence that ET-1 causes bronchoconstriction largely via ETB receptor stimulation [Hay 
1992, Battistini et al. 1994], Nagase et al. [1995] found that both ETA and ETB receptor 
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antagonists effectively reduce the ET-1-induced increases in airway resistance in vivo. In our 
examinations, IRL 1038, ETR-Pl/fl and the higher dose of BQ-610 significantly decreased 
the elevation in Raw induced by each of the ET-1 doses. Our data therefore indicate the role 
of both receptors in the ET-1-induced airway responses. 
We observed significant increases in the parenchymal parameters G, H and r\, which 
indicates changes in the mechanical properties of the parenchyma after ET-1. Pretreatment 
with IRL 1038, ETR-Pl/fl or the higher dose of BQ-610 significantly diminished the 
responses in H after each of the ET-1 doses. In parenchymal strips, Battistini et al. [1994] 
found that the ETA receptor antagonist BQ-123 inhibited the ET-1-induced contraction. 
Nagase et al. [1995] reported that BQ-123 did not alter the responses in Rti and lung elastance 
to ET-1; however, the ETB receptor antagonist BQ-788 significantly decreased the responses 
in both tissue parameters. In our experiments, pretreatment with both doses of BQ-610, IRL 
1038 or ETR-Pl/fl significantly reduced the changes in H after ET-1. These findings 
emphasized the roles of both types of ET receptors in the mediation of ET-1-induced 
constriction in the parenchyma. 
In the guinea pig lungs, it has been demonstrated that the ETA receptor antagonist BQ-123 
decreases the bronchoconstrictor responses to ET-1 in a dose-dependent manner [Noguchi et 
al. 1993, Battistini et al. 1994], In our experiments, pretreatment with BQ-610 in a dose of 20 
nmol/kg had no significant effect on the ET-1-induced airway and parenchymal responses. 
However, pretreatment with the higher dose significantly decreased the changes in the airway 
and parenchymal parameters. The dose-dependent effect of the ETA receptor antagonist BQ-
610 on the ET-1-induced pulmonary constriction provides additional evidence in favor of the 
hypothesis of other authors [Noguchi et al. 1993, Battistini et al. 1994, Hay and Luttmann 
1997] that there may be an ETA receptor antagonist-binding ETB receptor subtype in the 
guinea pig lung. 
Our study provides the first demonstration of the effects of the ETA receptor antagonist 
ETR-Pl/fl on the ET-l-induced mechanical changes in the lung. In the presence of ETR-Pl/fl, 
significantly smaller increases in Raw, G, H and r\ occurred after each dose of ET-1 than 
those observed in untreated animals. Moreover, the peptide decreased the durations of the 
significant changes in Raw, G and r\ after each ET-1 dose. Thus, ETR-Pl/fl affected the 
pulmonary mechanics in the same dose as did IRL 1038, but not BQ-610. Therefore, it is 
reasonable to suggest that ETR-Pl/fl is not selective for ETA receptors in the guinea pig lung. 
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These findings, similarly to those of Szalay et al. [ 1 9 9 8 ] , indicate that ETR-Pl/fl may 
antagonize not only the ETA, but also the ETB receptors. Another explanation may be that 
ETR-Pl/fl removes circulating E T - 1 , as was observed by Baranyi et al. [ 1 9 9 8 ] in dogs. 
ET-1 is known to be a proinflammatory mediator, as it induces intravascular leukocyte 
sequestration, and enhances albumin extravasation and edema formation in the guinea pig 
lung [Filep et al. 1995], The ET-l-induced edema is mediated by the ETA receptors in the 
trachea and the bronchi, but not in the parenchyma. In the present study, doses of ET-1 lower 
than those used by Filep et al. [1995] did not evoke lung edema, as evidenced by gravimetric 
and histological examinations. In agreement with our results, Macquin-Mavier et al. [1989] 
did not observe lung edema in ET-1-treated guinea pigs. 
It has been found that various mediators can also contribute to the ET-l-induced 
mechanical changes in the guinea pig lung. The bronchoconstriction elicited by ET-1 could be 
mediated by thromboxane A2 released via ET receptor activation [De Nucci et al. 1988, Pons 
et al. 1991, Lewis et al. 1998], ET-1 can release the bronchodilator prostacyclin [De Nucci et 
al. 1988] and nitric oxide [Lewis et al. 1998], Therefore, we suggest that the direct 
bronchoconstrictor effect of ET-1 can be either potentiated or counteracted by secondary 
mediators. 
In summary, we have characterized the pulmonary mechanical responses to the 
administration of ET-1, both with and without pretreatment with ETA and ETB receptor 
antagonists, with a method appropriate for the separate quantification of the airway and 
parenchymal components. The results reveal that the activation of both ETA and ETB receptor 
subtypes is involved in the mediation of the mechanical changes in response to ET-1 in the 
airways and the parenchyma. Since selective ETA receptor antagonist treatment suppressed 
the changes in the mechanical responses in a dose-related manner, we suggest the existence of 
a heterogeneous ETB receptor population in the guinea pig lung. 
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CONCLUSIONS 
The major findings of the present work are as follows. 
After iv. administration, the effects of histamine, methacholine, and endothelin-1 on the 
lung mechanical properties can be characterized by a dose-related constriction via different 
sites of action. 
In dogs, the responses of the airways and tissues to histamine were dissociated; 
histamine caused constriction in the lung periphery without changes in the bronchomotor 
tone. 
In rats, methacholine induced predominantly airway constriction, although an increase 
in the viscous resistance of the lung tissue also occurred as a result of the increased ventilation 
inhomogeneity. 
In guinea pigs, endothelin-1 elicited constriction in both the airways and the lung 
parenchyma; however, the effect in the peripheral airways appeared to predominate. 
In guinea pigs, both ETA and ETB receptor subtypes were involved in the mediation of 
the mechanical changes in the airways and lung tissue. The fact that a selective ETA receptor 
antagonist decreased the mechanical responses of the lung in a dose-related manner, supports 
the hypothesis that a heterogeneous ETB receptor population exists in the guinea pig lung. 
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